Binding of gluten-derived peptides to the HLA-DQ2 (α1*0501, β1*0201) molecule, assessed in a cellular assay

Clinical and Experimental Immunology

Volumn 111, Issue 1, 1998, Pages 158-165

  Shidrawi, R G ^a   Parnell, N D J ^a   Ciclitira, P J ^a   Travers, P ^b   Evan, G ^c   Rosen Bronson, S ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Binding; Coeliac disease; DQ2; HLA

Indexed keywords

EPITOPE; GLUTEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; PEPTIDE;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CELIAC DISEASE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; BINDING SITES; CELL LINE; GLUTEN; HLA-DQ ANTIGENS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 0031881590     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00448.x     Document Type: Article

References (35)

1. Sollid L, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J Exp Med 1984; 169:345-50.
2. Lundin KEA, Sollid LM, Qvigstad E et al. T Lymphocyte recognition of a celiac disease-associated cis- or trans-encoded HLA-DQ α/β heterodimer. J Immunol 1990; 145:136-9.
3. Sollid LM, Thorsby K. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993; 105:910-22.
4. Tighe MR, Hall M, Ashkenazi A, Siegler E, Lanchbury J, Ciclitira PJ. Coeliac disease among Ashkenazi jews from Israel: a study ot the HLA class II alleles and their association with disease susceptibility. Hum Immunol 1993; 38:270-5.
5. Ek J, Albrechtsen D, Solheim BG, Thorsby K. Strong association between the HLA-Dw3 and coeliac disease. Scand J Gastroenterol 1978; 13:229-33.
6. Lundin K, Scott H, Hansen T. Gliadin specific HLA-DQ (A1*0501, B1*0201) restricted T cells isolated from the small intestinal mucosa of coeliac patients. J Exp Med 1993; 178:187-96.
7. Trier JS. Celiac sprue. New Engl J Med 1991; 325:1709-19.
8. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. Gastroenterology 1992; 102:330-54.
9. MacDonald TT, Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 1988; 167:1341-9.
10. Lundin KEA, Sollid LM, Anthonsen D et al. Heterogeneous reactivity patterns of HLA-DQ restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology 1997; 112:752-9.
11. Shidrawi RG, Day P, Przemioslo RT, Ellis HJ, Nelufer JM, Ciclitira PJ. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol 1995; 30:758-62.
12. Sturgess RP, Day P, Ellis HJ et al. Wheat peptide challenge in coeliac disease. Lancet 1994; 343:758-61.
13. Gjertsen HA, Lundin KEA, Sollid LM, Eriksen JA, Thorsby E. T cells recognise a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ (α1*0501, β1*0201) heterodimer. Hum Immunol 1994; 39:243-52.
14. Johansen BH, Gjertsen HA, Vartdal H et al. Binding of peptides from the N-terminal region of α-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. Clin Immunol Immunopathol 1996; 79:288-93.
15. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM. Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol 1996; 8:177-82.
16. van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Koning F. Peptide binding characteristics of the coeliac disease-associated DQ (α1*0501, β1*0201) molecule. Immunogenetics 1996; 44:246-53.
17. Vartdal F, Johansen BH, Friede T et al. The peptide binding motif of the disease associated HLA-DQ (α1*0501, β1*0201) molecule. Eur J Immunol 1996; 26:2764-72.
18. Johansen BH, Buus S, Vartdal S et al. Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ (α1*0501, β1*0201) molecule. Int Immunol 1994; 6:453-61.
19. Kagnoff MR, Raleigh KA, Hubert JJ, Bernadin JF, Kasarda DD. Possible role of a human adenovirus in the pathogenesis of coeliac disease. J Exp Med 1984; 160:1544-7.
20. Tatham AS, Marsh MN, Wieser H, Shewry PR. Conformational studies of peptides corresponding to the coeliac-activating regions of wheat alpha gliadin. Biochem J 1990; 270:313-8.
21. Walls E, Crawford D. Lymphocytes - a practical approach. In: Klaus G, ed. Oxford: IRL Press, 1987: 149-62.
22. Long EO, Rosen-Bronson S, Karp D, Malnati M, Sekaly R, Jaraquemada D. Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells. Hum Immunol 1991; 31:229-35.
23. Jacobson S, Sekaly R, Jacobson C, McFarland H, Long E. HLA-class II restricted presentation of cytoplasmic measles-virus antigen to cytoxic T-cells. J Virol 1989; 63:1756-60.
24. Busch R, Strang G, Howland K, Rothbard J. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int Immunol 1990; 2:443-51.
25. Busch R, Rothbard J. Detection of peptide-MHC class II complexes on the surface of intact cells. J Immunol Methods 1990; 134:1-22.
26. Thorpe CJ, Travers PJ. Prediction of an HLA B44 binding motif by the alignment of known epitopes and molecular modelling of the antigen binding cleft. Immunogenetics 1994; 40:303-5.
27. Jurcavic S, Travers P, Hills A, Agrewala J, Moreno C, Ivanyi J. Distinct conformation of an HLA-permissive peptide when bound to HLA-DR1 or DRB5*0101 molecules. Int Immunol 1996; 8:1807-14.
28. Brown JH, Jardetsky TS, Gorga JC et al. Three-dimensional structure of class II histocompatihility antigen HLA-DR1. Nature 1993; 329:506-18.
29. Stern LJ, Brown JH, Jardetsky TS et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994; 368:215-21.
30. Sutcliffe M, Haneef I, Carney D, Blundell T. Knowledge based modelling of homologous proteins. Part I: three dimensional frameworks derived from the simultaneous superposition of multiple structures. Prot Eng 1987; 1:377-84.
31. Sutcliffe M, Hayes F, Blundell T. Knowledge based modelling of homologous proteins. Part II: rules for the conformations of substituted side chains. Prot Eng 1987; 1:385-92.
32. Horn G, Bugawan T, Long C, Manos M, Erlich H. Sequence analysis of HLA class II genes from insulin dependent diabetes individuals. Hum Immunol 1988; 21:249-254.
33. Gjertsen HA, Sollid LM, Ek J, Thorsby E, Lundin KEA. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol 1994; 39:567-74.
34. Jensen PE. Regulation of antigen presentation by acidic pH. J Exp Med 1990; 171:1779-84.
35. Mouritsen S, Hansen AS, Petersen BL, Buus S. pH dependence of the interaction between immunogenic peptides and MHC class II molecules. J Immunol 1992; 148:1438-44.